Abstract
Background
Colorectal cancer stem cells (Cr-CSCs) are involved in the growth of colon cancer, but their specific role in tumor biology, including metastasis, is still unclear. Currently, methods for sorting Cr-CSCs are based on the expression of surface markers (e.g., CD133+, CD44+, and aldehyde dehydrogenase 1 (ALDH1+)); however, the specificity of these markers for Cr-CSCs is uncertain.
Purpose
This study aimed to develop more effective ways of isolating and purifying Cr-CSCs.
Methods
Suspension culture was used for isolation of Cr-CSCs. And spheroid cells were performed by side population technology, and the putative molecular marker analysis of colorectal cancer stem cell. Migration assay and chemoresistance experiment were conducted between the adherent cells and spheroid cells.
Results
HT29 colon cancer cells grew well in suspension culture. The percentage of CD44+ cancer cell of spheroid cells was 68 times higher than that of adherent cells (89.5% vs. 1.3%), but there was no obvious difference in the percentage of CD133+ cells (6.25% vs. 5.6%). Moreover, it is worth noting that the percent of CD133 +/CD44+ cells remarkably rose (from 0.6% to 5.4%). The expression of ALDH1 was markedly increased (7.5% vs. 20.5%) for the spheroid cells than the adherent cells. The side population within the spheroid population dramatically increased from 0.2% to 6.3%. The resistance of spheroid cells to 5-FU was higher than that of adherent cells, as was their ability to migrate in the presence of SDF-1α.
Conclusion
Suspension culture is an effective approach for enriching Cr-CSCs and can provide an inexhaustible supply of genetically stable colon cancer stem cells for targeted Cr-CSC studies. Spheroid cell models also enable the study of colon cancer chemoresistance and metastasis and may help to elucidate the role of cancer stem cells in colon cancer.
Similar content being viewed by others
References
Mittal S, Mifflin R, Powell DW (2009) Cancer stem cells: the other face of Janus. Am J Med Sc 338:107–112
Scopelliti A, Cammareri P, Catalano V et al (2009) Therapeutic implications of cancer initiating cells. Expert Opin Biol Ther 9:1005–1016
Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111–115
O'Brien CA, Pollett A, Gallinger S et al (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110
Shmelkov SV, Butler JM, Hooper AT et al (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111–2120
Dalerba P, Dylla SJ, Park IK et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci 104:10158–10163
Huang EH, Hynes MJ, Zhang T et al (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382–3389
Deng S, Yang X, Lassus H et al (2009) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5:e10277
Bar EE, Lin A, Mahairak V et al (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177:1491–1502
Rappa G, Lorico A (2010) Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line. Exp Cell Res 316:1576–1586
Kanwar SS, Yu Y, Nautiyal J et al (2010) The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer 9:212–218
Goodell MA, Rosenzweig M, Kim H et al (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3:1337–1345
Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
Dey D, Saxena M, Paranjape AN et al (2009) Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 4:e5329
Todaro M, Alea MP, Di Stefano AB et al (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1:389–402
Yu F, Yao H, Zhu P et al (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109–1123
Miller RJ, Banisadr G, Bhattacharyya BJ (2008) CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 198:31–38
Hermann PC, Huber SL, Herrler T et al (2007) Distinct populations of cancer stem cells determines tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323
Acknowledgments
This work was supported by grants from the National Natural Science Foundation of China (30945201, 30973505), the Foundation of the Health Department of the Guangdong Province (A2009182), the Science and Technology Foundation of the Guangdong Province (2009B030801005, 2008B030301092), and the Foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests
The authors have declared that no competing interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, X., Ouyang, N., Teng, H. et al. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis 26, 1279–1285 (2011). https://doi.org/10.1007/s00384-011-1248-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1248-y